- In February 2026, Novanta Inc. reported fourth-quarter 2025 sales of US$258.35 million and net income of US$17.47 million, with full-year 2025 sales of US$980.60 million and net income of US$53.83 million, while also issuing 2026 GAAP revenue guidance of US$250–US$255 million for Q1 and US$1.03–US$1.05 billion for the year.
- The combination of higher sales but lower full-year net income, alongside quantified revenue expectations for 2026, gives investors fresh insight into how Novanta’s growth initiatives are affecting profitability and future top-line momentum.
- Next, we’ll examine how Novanta’s 2026 revenue guidance and mixed profit trends may alter the existing investment narrative around margin expansion.
The latest GPUs need a type of rare earth metal called Neodymium and there are only 29 companies in the world exploring or producing it. Find the list for free.
Novanta Investment Narrative Recap
To own Novanta, you need to believe its exposure to robotics, automation and advanced surgery can translate solid top-line growth into improving profitability over time. The latest results show sales rising but full-year net income lower, so the key near term catalyst is whether 2026 guidance around US$1.03–US$1.05 billion in revenue is accompanied by clearer progress on margins. For now, this update mainly reframes expectations rather than fundamentally changing the core opportunity or the biggest execution risks.
The most relevant recent announcement here is Novanta’s full-year 2026 revenue guidance of US$1,030–US$1,050 million, which builds on the 2025 sales base of US$980.60 million. Against prior concerns that organic growth in 2025 could be flat to slightly positive, this outlook matters because it anchors how investors think about the payoff from design wins in robotics, automation and medical devices, especially if these higher value applications can eventually support the margin expansion narrative.
Yet while the growth story is appealing, investors should be aware that ongoing trade disruptions and manufacturing regionalization could still pressure costs and margins if...
Read the full narrative on Novanta (it's free!)
Novanta's narrative projects $1.1 billion revenue and $135.3 million earnings by 2028.
Uncover how Novanta's forecasts yield a $160.00 fair value, a 22% upside to its current price.
Exploring Other Perspectives
Three Simply Wall St Community valuations for Novanta range from US$112.45 to US$160. With that spread in mind, remember that margin pressure from tariffs and regionalization could influence how sustainably the company converts revenue growth into earnings over time, so it is worth comparing several independent views.
Explore 3 other fair value estimates on Novanta - why the stock might be worth as much as 22% more than the current price!
Decide For Yourself
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Novanta research is our analysis highlighting 1 key reward and 1 important warning sign that could impact your investment decision.
- Our free Novanta research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Novanta's overall financial health at a glance.
Ready To Venture Into Other Investment Styles?
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
- The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 20 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
- The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Uncover the next big thing with 30 elite penny stocks that balance risk and reward.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com